Cite
APA Citation
Moia, R., Boggio, E., Gigliotti, L., Crisà, E., De Paoli, L., Margiotta Casaluci, G., Rolla, R., Patriarca, A., Gaidano, G., Dianzani, U., & Bruna, R. (2020). anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. Hematological oncology, 38(2), 204–206. http://access.bl.uk/ark:/81055/vdc_100102565064.0x00004e